There's a lot of noise around peptides right now so here's what actually changed. The FDA has begun reviewing several peptides that were previously placed on its do not compound list. By The Hidden Risks of BPC157: What Patients Need to Know About Contamination and Safety Regenexx at New Regeneration Orthopedics When Systems Fail: Lessons from an FDA Warning Letter Drug Safety and Pharmacovigilance Course FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC